The situation that the world has faced during the last two years has left valuable lessons. In the first place is the importance of hygiene and personal protection to prevent multiple diseases. But there is also the clinical research for his role in the development of new drugs. It is the basis for obtaining other alternatives that allow facing the recent challenges for the benefit of world health.
The clearest example is the design of the Covid-19 vaccine. Although it was achieved in record time, a millionaire investment and multiple previous studies were necessary. That is why it is vital to promote research work to be prepared for possible future pandemics.
On the other hand, although it may be thought that clinical research is exclusive to developed countries, in reality this is not entirely true. The clearest example is EtCurae because it has positioned itself as a leader in Latin America. Your goal is democratize access to new health technologies through innovation in order to improve the quality of life of patients.
What is your job?
It is an organization that acts as facilitator in clinical research of health institutions. It does so through investment in infrastructure and training support for the specialization of health professionals in clinical research. In addition to quality management in clinical research in compliance with national and international regulatory agencies.
Those responsible for its foundation
The pillars of Et Curae are important elements of the clinical research. After a decade as a consultant in the development of initiatives and businesses in the health sector, Alexander Angeles co-founded in 2018 EtCuraewith experience as a consultant and independent member of platforms such as SPARK of Stanford University, Health Think Tank Group of the British Chamber of Commerce in Mexico, Up Global, Global Citizens, among others.
Patricia Campa is another of the founding partners, who serves as Director of Operations. She has more than 10 years of experience in the field of health research. She has participated as an evaluator and judge for new health technology projects, as well as studies focused on leadership in health and social entrepreneurship.
And the third member of the team, Dr Sitaramraju Yarramraju, Doctor of Pharmaceutical Sciences from the University of KULEUVEN, Belgium with more than 20 years of experience in pharmaceutical development in academia, industry and in contract research organizations (CRO) at different functional levels. He is in charge of providing strategic solutions for the management of the life cycle of pharmaceutical, biotechnological and health products.
EtCurae currently offers 600 scholarships for health professionals in the State of Mexico. They aim to train participants in Good Clinical Practices according to international regulations that will serve for the training of personnel participating in a clinical trial. In addition to having the recognition of the Mutual Recognition Program of Transcelerate Biopharma Inc.
The experience of the team has managed to position EtCurae as one of the management organizations with the greatest reach in Latin America. All of this points to a stabilizing management strategy with a direct and indirect investment model as well as transparency and regulatory compliance.